Retatrutide 20 mg

£115.00

Category:

Retatrutide 20mg (LY3437943) – High-Purity Research Peptide UK

Overview

Retatrutide 20mg is a premium research-grade presentation of retatrutide (development code: LY3437943), a novel peptide that has garnered significant interest in the field of metabolic and obesity research. Unlike earlier compounds, retatrutide is notable for targeting three hormone-receptor pathways simultaneously.
Clinical research published on this compound has driven a surge in search interest for terms like Retatrutide 20mg UK, Retatrutide weight loss research, and Retatrutide vs tirzepatide. Please note: the “20mg” denotes the total amount of lyophilised material in this specific vial presentation. It is not a recommended or established clinical dose. This product is strictly for in-vitro laboratory research.

What Is Retatrutide 20mg?

Retatrutide is an investigational, peptide-based compound that acts as a triple hormone receptor agonist. It uniquely targets:
  1. GIP (Glucose-dependent insulinotropic polypeptide) receptor
  2. GLP-1 (Glucagon-like peptide-1) receptor
  3. Glucagon receptor
This differentiates it from semaglutide (which primarily targets the GLP-1 receptor) and tirzepatide (a dual GIP and GLP-1 receptor agonist). The addition of glucagon-receptor activity makes retatrutide a highly compelling compound for researchers studying incretins, energy balance, and metabolic signalling.

How Does Retatrutide Work?

The research interest in retatrutide stems from the synergistic effects of its three signalling pathways:
  • GLP-1 Activation: Regulates appetite, improves glucose regulation, and slows gastric emptying.
  • GIP Activation: Enhances metabolic and insulin-related signalling, working synergistically with GLP-1.
  • Glucagon Activation: Plays a vital role in hepatic glucose production and overall energy metabolism, potentially increasing energy expenditure.
This multi-receptor activation is a primary factor driving its popularity in advanced metabolic research.

Retatrutide and Weight-Loss Research

Retatrutide weight loss is one of the most researched topics in the UK metabolic science community. Interest is heavily fueled by results from controlled clinical trials.
In a notable Phase 2 clinical trial assessing various doses of retatrutide over 48 weeks, 338 adults with obesity or overweight (and a weight-related condition) were studied. The results showed:
  • 12mg regimen: Participants lost an average of 24.2% of their body weight.
  • Placebo group: Participants lost an average of 2.1% of their body weight.
  • Other regimens studied: 1mg, 4mg, and 8mg.
Disclaimer: These results are from controlled clinical-trial protocols. They are provided for informational and research-comparison purposes only and do not imply that a 20mg vial is a single clinical dose.

Retatrutide vs Semaglutide vs Tirzepatide

The easiest way to understand the pharmacological differences between these researched compounds is through their receptor activity:
Compound
Receptor Activity
Classification
Semaglutide
GLP-1
Single receptor agonist
Tirzepatide
GIP + GLP-1
Dual receptor agonist
Retatrutide
GIP + GLP-1 + Glucagon
Triple receptor agonist
This triple-receptor mechanism does not automatically mean retatrutide is “superior”; rather, it represents a distinct pharmacological approach that researchers are actively investigating for synergistic metabolic effects.

What Does “20mg” Mean in Retatrutide 20mg?

The “20mg” refers to the total stated quantity of retatrutide peptide contained within the sealed vial. This distinction is critical, as published clinical research utilizes specific, titrated dosing schedules (e.g., 1mg to 12mg). A 20mg vial is a bulk research presentation intended for laboratory measurement and dilution, not a single-use dose.

Retatrutide 20mg UK: Quality & Research Standards

When assessing the quality of Retatrutide 20mg in the UK, researchers must prioritize scientific rigor. At XL Peptide, we ensure our research materials meet the highest standards. When sourcing research peptides, always verify:
  • ✅ Batch Identification: Unique batch ID on every vial for full traceability.
  • ✅ Analytical Testing: ≥99% purity confirmed by HPLC (High-Performance Liquid Chromatography).
  • ✅ Identity Confirmation: Verified by Mass Spectrometry (MS).
  • ✅ Transparency: Access to a batch-specific Certificate of Analysis (COA) and independent third-party verification.

Product Specifications

  • Compound: Retatrutide (LY3437943)
  • Form: Lyophilised (freeze-dried) powder
  • Purity: ≥99% (Confirmed by HPLC)
  • Identity: Confirmed by Mass Spectrometry (MS)
  • Presentation: Sterile-sealed research vial
  • Intended Use: In-vitro laboratory research only. Not for human consumption.
  • Storage: −20°C, protected from light and moisture.
  • Origin: Dispatched directly from the UK.

Storage & Handling Guidelines

Proper handling ensures the integrity of your research materials:
  • Before Reconstitution: Store lyophilised powder at −20°C, sealed, and away from light and moisture.
  • After Reconstitution: Keep refrigerated at 2–8°C and use within the timeframe indicated in the provided storage guide.
  • Handling: Allow vials to reach room temperature before opening to reduce condensation on the rubber seal.
  • Documentation: Always record the batch number and reconstitution date for research traceability.

Frequently Asked Questions (FAQ)

What is Retatrutide 20mg?
Retatrutide 20mg refers to a research vial containing a total of 20mg of the investigational peptide retatrutide (LY3437943). It is a triple receptor agonist targeting GIP, GLP-1, and glucagon receptors, used strictly for in-vitro metabolic research.
What does 20mg mean in Retatrutide 20mg?
The “20mg” indicates the total net weight of the lyophilised peptide powder inside the vial. It is a bulk research presentation, not a recommended single clinical dose. Researchers must calculate and dilute their own specific research concentrations.
How does Retatrutide 20mg work?
Retatrutide works by simultaneously activating three hormone receptors: GIP, GLP-1, and glucagon. This triple-agonist action influences appetite regulation, glucose metabolism, and energy expenditure, making it a key subject in metabolic research.
What is Retatrutide 20mg also known as?
In scientific literature and clinical trials, retatrutide is commonly referred to by its developmental code name: LY3437943.
What does the research show about Retatrutide?
Phase 2 clinical trials have shown that retatrutide can induce significant weight reduction (up to 24.2% over 48 weeks at a 12mg regimen) compared to placebo (2.1%), alongside improvements in metabolic markers.
Why are researchers interested in Retatrutide 20mg?
Researchers are interested in its unique triple-receptor mechanism. The addition of glucagon receptor agonism to the established GIP/GLP-1 pathway may offer enhanced energy expenditure and metabolic benefits not seen in dual or single agonists.
How does Retatrutide compare with semaglutide and tirzepatide?
Semaglutide is a single GLP-1 agonist. Tirzepatide is a dual GIP/GLP-1 agonist. Retatrutide is a triple agonist (GIP/GLP-1/Glucagon), representing a newer, more complex pharmacological approach to metabolic research.
How should Retatrutide 20mg be stored?
Unreconstituted retatrutide should be stored at −20°C, protected from light and moisture. Once reconstituted with bacteriostatic water, it should be refrigerated at 2–8°C and used within the recommended research timeframe.
What should researchers look for when choosing Retatrutide 20mg?
Always look for ≥99% HPLC purity, mass spectrometry identity confirmation, a unique batch ID, and a readily available, batch-specific Certificate of Analysis (COA) from a trusted UK supplier like XL Peptide.
Where can I buy Retatrutide 20mg in the UK?
XL Peptide supplies high-purity Retatrutide 20mg (LY3437943) directly from the UK. All orders include third-party testing verification and are dispatched in temperature-conscious, discreet packaging.

UK Shipping & Delivery

Orders placed before 15:00 GMT on a working day are dispatched the same day from our UK facility. We use temperature-conscious, discreet packaging to ensure the integrity of your research peptides.
  • UK Tracked Delivery: 1–2 working days · from £3.95
  • International Shipping: Calculated at checkout based on destination and customs requirements.

Reviews

There are no reviews yet.

Be the first to review “Retatrutide 20 mg”

Your email address will not be published. Required fields are marked *

Shopping Cart